resveratrol has been researched along with e 7010 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Feng, F; Li, Q; Liu, W; Liu, Y; Sun, H; Xing, S | 1 |
| Ali Hussaini, SM; Ashraf, M; Basha, ST; Kamal, A; Kiran, B; Singh, S; Sridhar, B; Vishnuvardhan, MV | 1 |
2 other study(ies) available for resveratrol and e 7010
| Article | Year |
|---|---|
p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators.
Topics: Animals; Atherosclerosis; Autophagy; Humans; Neurodegenerative Diseases; Osteitis Deformans; Protein Domains; Sequestosome-1 Protein; Signal Transduction; Tumor Suppressor Proteins | 2020 |
Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.
Topics: Aminophenols; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Polymerization; Resveratrol; Stilbenes; Structure-Activity Relationship; Sulfonamides; Tubulin; Tubulin Modulators | 2016 |